BioPharmSignal logoBioPharmSignal

Biotech News

Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

Rapid Micro Biosystems (RPID)Rapid Micro BiosystemsCompany update

LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products,

Related news

RPIDRapid Micro Biosystems2025-10-30 20:45 EST

Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference

RPIDRapid Micro Biosystems2026-01-07 14:00 EST

Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

View all latest news

Rapid Micro Biosystems

Automated Microbial Quality Control Rapid Micro Biosystems provides automation systems used to test biologics, vaccines, cell and gene therapies, sterile injectables, and other healthcare products for microbial contamination. Growth Direct Platform The Growth Direct system replaces manual microbial quality-control workflows with...

Recent company news

RPIDRapid Micro Biosystems2026-08-07 11:00 EST

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

RPIDRapid Micro Biosystems2026-08-04 20:30 EST

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RPIDRapid Micro Biosystems2026-07-23 21:15 EST

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

RPIDRapid Micro Biosystems2026-06-10 20:30 EST

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

RPIDRapid Micro Biosystems2026-05-19 01:55 EST

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

Stock data

Close
1.68 USD
Market cap
97.65M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States